All In MedTech

Device Trial Radar · NCT02655887

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease

The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)

Last checked: Nov 20, 2026Latest source record: Feb 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

170

Actual

Start

Jun 15, 2016

Primary completion

Jun 19, 2018

Study completion Oct 30, 2020

Sponsor

Lead sponsor
C. R. BardPublic (BDX)
Sponsor type
Industry
First posted
Jan 14, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The BARD® Venovo™ Venous Stent Study is a non-randomized clinical study intended to collect confirmatory evidence of the safety and effectiveness of the Venous Stent for the treatment of iliofemoral occlusive disease.

Conditions

  • May-Thurner Syndrome
  • Peripheral Vascular Disease
  • Venous Disease
  • Iliofemoral Occlusive Disease

Interventions

  • VENOVO™ Venous StentDevice

    VENOVO™ Venous stent placement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Primary Patency of the Venous Stent at 12 Months Post-Index ProcedureTime frame: 12 months post-index procedure

1 more outcomes with a free account

Locations

21 sites in 7 countries. Site status is shown where the registry gives one.

  • Vascular Breakthroughs, LLC

    Darien, Connecticut

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.